Article info
PDFNeurological rarities
Vogt-Koyanagi-Harada disease
- Correspondence to Dr Duncan Street, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK; dstreet22{at}doctors.org.uk
Citation
Vogt-Koyanagi-Harada disease
Publication history
- Received November 21, 2018
- Revised December 18, 2018
- Accepted January 22, 2019
- First published March 19, 2019.
Online issue publication
June 23, 2020
Article Versions
- Previous version (23 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Vogt-Koyanagi-Harada syndrome: what neurologists need to know
- Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease
- Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids
- Delayed fellow eye involvement in patients with Vogt–Koyanagi–Harada disease
- The outcomes of indocyanine green angiography monitored immunotherapy in Vogt–Koyanagi–Harada disease
- Blue light and near-infrared fundus autofluorescence in acute Vogt–Koyanagi–Harada disease
- Enhanced depth imaging optical coherence tomography in long-standing Vogt–Koyanagi–Harada disease
- Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes)
- Unique clinical spectrum with distinguishing diagnostic features in Vogt-Koyanagi-Harada syndrome
- Changes of choroidal structure after corticosteroid treatment in eyes with Vogt–Koyanagi–Harada disease